Small intestine‐targeted endoscopic bariatrics: Current status and future perspectives
Digestive Endoscopy · 2023
DOI: 10.1111/den.14575 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Digestive Endoscopy, 2023. Verfasst von Mengting Ren und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Bariatric Surgery, Diabetes Mellitus, Type 2, Bariatrics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Key Research and Development Program of Zhejiang Province, Department of Science and Technology of Zhejiang Province.
Abstract (Originalsprache)
The global obesity epidemic shows no signs of slowing down. Endoscopic bariatric and metabolic therapies (EBMTs) are being increasingly adopted as treatment options for obesity and obesity‐related comorbidities, due to their minimally invasive nature and ease of delivery. According to the site of action along the gastrointestinal tract, EBMTs can be divided into two categories: gastric EBMTs, and small intestine‐targeted EBMTs. Unlike gastric EBMTs, which work through a volume‐restricting mechanism leading to early satiety and reduced caloric intake, small intestine‐targeted EBMTs can be metabolically beneficial through foregut and/or hindgut pathways independent of weight loss, and therefore have great potential for the treatment of obesity‐related metabolic comorbidities such as type 2 diabetes. Although none of the small intestine‐targeted EBMTs have been approved by the US Food and Drug Administration to date, their clinical efficacy and safety have been extensively explored in investigational trials. This review aims to summarize and provide a comprehensive understanding of small intestine‐targeted EBMTs in clinical and preclinical settings, and to further discuss their potential mechanisms of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Mengting Ren
Förderung
- Key Research and Development Program of Zhejiang Province, Department of Science and Technology of Zhejiang Province
Zitieren
APA
Ren, M., & Ji, F. (2023). Small intestine‐targeted endoscopic bariatrics: Current status and future perspectives. Digestive Endoscopy. https://doi.org/10.1111/den.14575
Vancouver
Ren M, Ji F. Small intestine‐targeted endoscopic bariatrics: Current status and future perspectives. Digestive Endoscopy. 2023. doi:10.1111/den.14575
BibTeX
@article{Ren2023,
author = {Ren, Mengting and Ji, Feng},
title = {Small intestine‐targeted endoscopic bariatrics: Current status and future perspectives},
journal = {Digestive Endoscopy},
year = {2023},
doi = {10.1111/den.14575}
}
EUVIMED